Latest Drug approvals News
NOT REAL NEWS: A look at what didn't happen this week
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: ___ Posts misidentify photos of trans...
California delays coronavirus vaccine mandate for schools
SACRAMENTO, Calif. (AP) — California is sticking with its coronavirus vaccine mandate for schoolchildren, but it won't happen until at least the summer of 2023, Gov. Gavin Newsom's administration announced Thursday. Last year, California was the first state to announce it would...
New Jersey to start recreational marijuana sales April 21
TRENTON, N.J. (AP) — Recreational marijuana sales in New Jersey for those 21 and older will begin April 21, Democratic Gov. Phil Murphy said Thursday. “This is a historic step in our work to create a new cannabis industry,” said Murphy, who made the announcement via Twitter. ...
Medical clinic to pay $120,000 for importing medication
MOUNT VERNON, Wash. (AP) — A Mount Vernon medical practice will pay $120,000 to the federal and state governments in a settlement for unlawfully importing medications from a foreign source. The U.S. Attorney’s Office in Seattle said the Skagit Family Health Clinic imported birth...
NJ approves 7 facilities for recreational cannabis sales
TRENTON, N.J. (AP) — New Jersey regulators gave a green light Monday to seven facilities that already sell medical marijuana to also sell recreational cannabis, although it's not clear exactly when sales would begin. Sales could start in a matter of weeks or longer, but a specific...
Board: Physician-legislator's COVID directive has no weight
KANSAS CITY, Mo. (AP) — The Kansas board that licenses health care providers raised concerns Friday about a letter that a physician-legislator sent to doctors suggesting that they prescribe ivermectin and other medications that aren’t approved to treat the virus. The Kansas Board...
Medicare weighs premium cut after limiting Alzheimer's drug
WASHINGTON (AP) — Medicare said Thursday it's considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer's drug projected to drive up program costs. The agency “is looking at that, and is still going...
FDA panel narrowly sides against experimental ALS drug
WASHINGTON (AP) — Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease, a potential setback for patient groups who have lobbied for the medication’s approval. Advisers to the Food and Drug...
FDA skeptical of benefits from experimental ALS drug
WASHINGTON (AP) — Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval. The drug from Amylyx Pharmaceuticals has...
Pressured by patients, FDA reviews ALS drug with modest data
WASHINGTON (AP) — When patients are battling a terminal illness and want access to an experimental drug, how much evidence that it works should regulators require before approval? That’s the question behind many of the Food and Drug Administration’s toughest decisions,...
